Correlation Between Vext Science and THC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vext Science and THC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vext Science and THC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vext Science and THC Therapeutics, you can compare the effects of market volatilities on Vext Science and THC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vext Science with a short position of THC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vext Science and THC Therapeutics.
Diversification Opportunities for Vext Science and THC Therapeutics
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vext and THC is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Vext Science and THC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on THC Therapeutics and Vext Science is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vext Science are associated (or correlated) with THC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of THC Therapeutics has no effect on the direction of Vext Science i.e., Vext Science and THC Therapeutics go up and down completely randomly.
Pair Corralation between Vext Science and THC Therapeutics
Assuming the 90 days horizon Vext Science is expected to under-perform the THC Therapeutics. But the otc stock apears to be less risky and, when comparing its historical volatility, Vext Science is 17.14 times less risky than THC Therapeutics. The otc stock trades about -0.07 of its potential returns per unit of risk. The THC Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 0.30 in THC Therapeutics on September 12, 2024 and sell it today you would lose (0.23) from holding THC Therapeutics or give up 76.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Vext Science vs. THC Therapeutics
Performance |
Timeline |
Vext Science |
THC Therapeutics |
Vext Science and THC Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vext Science and THC Therapeutics
The main advantage of trading using opposite Vext Science and THC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vext Science position performs unexpectedly, THC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in THC Therapeutics will offset losses from the drop in THC Therapeutics' long position.Vext Science vs. 4Front Ventures Corp | Vext Science vs. Khiron Life Sciences | Vext Science vs. BellRock Brands | Vext Science vs. Elixinol Global |
THC Therapeutics vs. Grey Cloak Tech | THC Therapeutics vs. CuraScientific Corp | THC Therapeutics vs. Love Hemp Group | THC Therapeutics vs. Greater Cannabis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |